SWEDISH MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1910-01-01

Employees: -

Market Cap: -

Website: http://www.swedish.org/

Clinical Trials

Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial

Not Applicable

Recruiting

Conditions: Primary Spontaneous Pneumothorax

Interventions: Procedure: Early Chest Tube Removal
Procedure: Standard Chest Tube Removal
Device: Apical Chest Tube

First Posted Date: 2024-05-13

Last Posted Date: 2024-05-13

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 200

Registration Number: NCT06411431

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

Minimally Invasive Esophagectomy Pain Control Trial

Phase 1

Recruiting

Conditions: Postoperative Complications
Postoperative Pain, Acute

Interventions: Procedure: Thoracic epidural catheter
Procedure: Local intercostal nerve block
Procedure: Cryo-analgesia and intercostal nerve block
Procedure: Serratus plane catheter blocks and intercostal nerve blocks

First Posted Date: 2023-06-15

Last Posted Date: 2023-06-15

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 30

Registration Number: NCT05906134

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Early Phase 1

Recruiting

Conditions: Newly Diagnosed Glioblastoma

Interventions: Drug: combinations of up to 3 FDA approved drugs from a panel of compounds

First Posted Date: 2022-05-18

Last Posted Date: 2024-05-08

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 10

Registration Number: NCT05380349

Locations: 🇺🇸
Swedish Medical Center, Seattle, Washington, United States

Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy

Phase 2

Terminated

Conditions: Covid19
SARS-CoV Infection

Interventions: Dietary Supplement: Zinc Picolinate Placebo
Dietary Supplement: Zinc Picolinate
Dietary Supplement: Resveratrol Placebo
Dietary Supplement: Resveratrol

First Posted Date: 2020-09-09

Last Posted Date: 2022-07-29

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 45

Registration Number: NCT04542993

Locations: 🇺🇸
Swedish Medical Center, Seattle, Washington, United States

Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome

Phase 4

Withdrawn

Conditions: Levator Ani Syndrome

Interventions: Drug: Diazepam Tablets

First Posted Date: 2020-01-03

Last Posted Date: 2023-04-19

Lead Sponsor: Swedish Medical Center

Registration Number: NCT04216797

Locations: 🇺🇸
Swedish Medical Center Colon Rectal Clinic, Seattle, Washington, United States

Management of Pleural Space Infections

Phase 4

Completed

Conditions: Empyema, Pleural
Parapneumonic Effusion

Interventions: Drug: Intrapleural Medications
Procedure: Surgery
Procedure: Pleural Sampling
Procedure: Pleural fluid drainage
Radiation: Protocol Image #1
Other: Surgical Consultation
Behavioral: Quality of Life

First Posted Date: 2019-03-13

Last Posted Date: 2022-11-22

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 26

Registration Number: NCT03873766

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL

Phase 2

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Carboplatin
Drug: Ifosfamide
Drug: Etoposide
Biological: Rituximab
Drug: Carmustine
Drug: Cytarabine
Drug: Melphalan
Other: Autologous HSCT
Drug: Acalabrutinib

First Posted Date: 2018-11-09

Last Posted Date: 2022-07-22

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 47

Registration Number: NCT03736616

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Allopurinol
Drug: Carmustine
Drug: Melphalan
Drug: Etoposide
Drug: Cytarabine

First Posted Date: 2018-06-27

Last Posted Date: 2022-06-22

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 100

Registration Number: NCT03570983

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

Unobtrusive Sensing of Medication Intake ("USE-MI")

Not Applicable

Recruiting

Conditions: Medication Adherence

Interventions: Behavioral: USE-MI System

First Posted Date: 2018-06-27

Last Posted Date: 2022-04-28

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 60

Registration Number: NCT03571022

Locations: 🇺🇸
Swedish Medical Center, Seattle, Washington, United States

A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy

Not Applicable

Terminated

Conditions: Esophageal Cancer
Pain, Postoperative

Interventions: Procedure: Esophagectomy
Procedure: Transversus abdominis plane catheter
Procedure: Epidural

First Posted Date: 2018-06-27

Last Posted Date: 2023-01-23

Lead Sponsor: Swedish Medical Center

Target Recruit Count: 38

Registration Number: NCT03570996

Locations: 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy